Mucosal macrophages: Phenotype and functionality in homeostasis and pathology

Handbook of Macrophages: Life Cycle, Functions and Diseases

Volumn , Issue , 2012, Pages 121-145

  Foey, Andrew ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878443234     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (124)

1. Anderson, C.F. and Mosser, D.M. 2002. A novel phenotype for an activated macrophage: the type 2 activated macrophage. Journal of Leukocyte Biology 72(1):101-106.
2. Anderson, C.F. and Mosser, D.M. 2002. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. Journal of Immunology 168(8):3697-3701.
3. Avdiushko, R., Hongo, D., Lake-Bullock, H., Kaplan, A. and Cohen, D. 2001. IL-10 receptor dysfunction in macrophages during chronic inflammation. Journal of Leukocyte Biology 70:624-632.
4. Balkwill, F. and Mantovani, A. 2001. Inflammation and cancer: back to Virchow? Lancet 357:539-545.
5. Balm, F.J., Drexhage, H.A., von Blomberg, M.E. and Snow, G.B. 1982. Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes. Laryngoscope 92:810-814.
6. Bastos, K.R., Alvarez, J.M., Marinho, C.R., Rizzo, L.V. and Lima, M.R. 2002. Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. Journal of Leukocyte Biology 71(2):271-278.
7. Belge, K-U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T. and Ziegler-Heitbrock, L. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. Journal of Immunology 168:3536-3542.
8. Bondeson, J., Browne, K.A., Brennan, F.M., Foxwell, B.M.J. and Feldmann, M. 1999. Selective regulation of cytokine induction by adenoviral gene transfer of IkBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but not IL-10 is nuclear factor-kB independent. Journal of Immunology 162:2939-2945.
9. Bouchon, A., Dietrich, J. and Colonna, M. 2000. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. Journal of Immunology 164:4991-4995.
10. Bouma, G. and Strober, W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nature Reviews Immunology 3:521-533.
11. Braat, H., McGuirk, P., Ten Kate, F.J.W., Huibregtse, I., Dunne, P.J., Hommes, D.W., Van Deventer, S.J.H. and Mills, K.H.G. 2007. Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule. Gut. 56:351-357.
12. Brown, N.S., Jones, A., Fujiyama, C., Harris, A.L. and Bicknell, R. 2000. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Research 60:6298-6302.
13. Buno, I.J., Huff, J.C., Weston, W.L., Cook, D.T. and Brice, S.L. 1998. Elevated levels of interferon gamma, tumour necrosis factor alpha, interleukins 2, 4 and 5, but not interleukin-10 are present in recurrent aphthous stomatitis. Archives in Dermatology 134:827-831.
14. Candia, E., Diaz-Jimenez, D., Langjahr, P., Nunez, L.E., de la Fuente, M., Farfan, N., Lopez-Kostner, F., Abedrapo, M., Alvarez-Lobos, M., Pinedo, G., Beltran, C.J., Gonzalez, C., Gonzalez, M.-J., Quera, R. and Hermoso, M.A. 2011. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology doi:10.1016/j.imbio.2011.10.023.
15. Canto, E., Ricart, E., Montford, D., Gonzalez-Juan, D., Balanzo, J., Rodriguez-Sanchez, J.L. and Vidal, S. 2006. TNF-alpha production to TLR2 ligands in active IBD patients. Clinical Immunology 119(2): 156-165.
16. Chehade, M. and Mayer, L. 2005. Oral tolerance and its relation to food hypersensitivities. Current Reviews of Allergy and Clinical Immunology 115(1):3-12.
17. Chizziolini, C., Rezzonico, R., De Luca, C., Burger, D. and Dayer, J.-M. 2000. Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. Journal of Immunology 164:5952-5960.
18. Cho, J.H. 2008. The genetics and immunopathogenesis of inflammatory bowel disease. Nature Reviews in Immunology 8:458-466.
19. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H. and de Vries, J.E. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. Journal of Experimental Medicine 174:915-924.
20. Drexler, S.K., Kong, P., Inglis, J., Williams, R.O., Garlanda, C., Mantovani, A., Yazdi, A.S., Brennan, F., Feldmann, M. and Foxwell, B.M.J. 2010. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signalling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis and Rheumatism 62(8):2249-2261.
21. Fingerle, G., Pforte, A., Passlick, B., Blumenstein, M., Strobel, M. and Ziegler-Heitbrock, H.W. 1993. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82(10):3170-3176.
22. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. and O'Garra, A. 1991. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147:3815-3822.
23. Fleming, S.D. and Campbell, P.A. 1996. Macrophages have cell surface IL-10 that regulates macrophage bacteriocidal activity. Journal of Immunology 156:1143-1150.
24. Fong, C.H.Y., Bebien, M., Didierlaurent, A., Nebauer, R., Hussell, T., Broide, D., Karin, M. and Lawrence, T. 2008. An anti-inflammatory role for IKKβ through the inhibition of "classical" macrophage activation. Journal of Experimental Medicine 205(6):1269-1276.
25. Foster-Cuevas, M., Wright, G.J., Puklavec, M.J., Brown, M.H. and Barclay, A.N. 2004. Human Herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. Journal of Virology 78(14):7667-7676.
26. Geissmann, F., Jung, S. and Littman, D.R. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
27. Gerber, J.S. and Mosser, D.M. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. Journal of Immunology 166(11):6861-6868.
28. Gibbs, D.F., Warner, R.L., Weiss, S.J., Johnson, K.J. and Varani, J. 1999a. Characterisation of matrix metalloproteinases produced by rat alveolar macrophages. American Journal of Respiratory and Cell Molecular Biology 20:1136-1144.
29. Gibbs, D.F., Shanley, T.P., Warner, R.L., Murphy, H.S., Varani, J. and Johnson, K.J. 1999b. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. American Journal of Respiratory and Cell Molecular Biology 20:1145-1154.
30. Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. and Sansonetti, P.J. 2003. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry 278(11): 8869-8872.
31. Gollenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K., and Raetz, C.R. 1991. Lipid A-like molecules that antagonise the effects of endotoxins on human monocytes. Journal of Biological Chemistry 266:19490-19498.
32. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D.C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R.R., Wiedenmann, B., Dignass, A.U. and Sturm, A. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via Toll-like receptor 2- and Toll-like receptor 4-dependent pathways. Infection and Immunity 74(7):4075-4082.
33. Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C.E., Schledzewski, K. and Goerdt, S. 2001. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein beta IG-H3. Scandinavian Journal of Immunology 53(4):386-392.
34. Grazia-Cappiello, M., Sutterwala, F.S., Trinchieri, G., Mosser, D.M. and Ma, X. 2001. Suppression of IL-12 transcription in macrophages following Fc gamma receptor ligation. Journal of Immunology 166(7):4498-4506.
35. Hagemann, T., Lawrence, T., McNeish, I., Charles, K.A., Kulbe, H., Thompson, R.G., Robinson, S.C. and Balkwill, F.R. 2008. Re-educating tumour-associated macrophages by targeting NF-kappaB. Journal of Experimental Medicine 205:1261-1268.
36. Hamerman, J.A., Jarjoura, J.R., Humphrey, M.B., Hakamura, M.C., Seaman, W.E. and Lanier, L.L. 2006. Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. Journal of Immunology 177(4):2051-2055.
37. Haroon, Z.A., Lai, T.S., Hettasch, J.M., Lindberg, R.A., Dewhirst, M.W. and Greenberg, C.S. 1999. Tissue transglutaminase is expressed as a host response to tumour invasion and inhibits tumour growth. Laboratory Investigation 79:1679-1686.
38. Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T., Scholmerich, J., Herfarth, H., Ray, K., Falk, W. and Rogler, G. 2002. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122:1987-2000.
39. Hesse, M., Modolell, M., La Flamme, A.L., Schito, M., Fuentes, J.M., Cheever, A.W., Pearce, E.J. and Wynn, T.A. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. Journal of Immunology 167:6533-6544.
40. Hoving, J.C., Kirstein, F., Nieuwenhuizen, N.E., Fick, L.C., Hobeika, E., Reth, M. and Brombacher, F. 2012. B cells that produce immunoglobulin E mediate colitis in Balb/c mice. Gastroenterology 142(1):96-108.
41. Hume, D.A., Allan, W., Hogan, P.G. and Doe, W.F. 1987. Immunohistochemical characterisation of macrophages in the liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1 and the mature macrophage marker 25F9 in normal and diseased tissue. Journal of Leukocyte Biology 42:474-484.
42. Hunter, M.H., Wang, A., Hirota, C.L. and McKay, D.M. 2005. Neutralising anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. Journal of Immunology 174:7368-7375.
43. Inohara, N. and Nunez, G. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nature Reviews in Immunology 3:371-382.
44. Kamada, N., Hisamatsu, T., Okamoto, S., Sato, T., Matsuka, K., Arai, K., Nakai, T., Hasegawa, A., Inoue, N., Watanabe, N., Akagawa, K.S. and Hibi, T. 2005. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. Journal of Immunology 175:6900-6908.
45. Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M.T., Sugita, A., Koganei, K., Akagawa, K.S. and Hibi, T. 2008. Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn's disease via IL-23/IFNγ axis. Journal of Clinical Investigation 118(6):2269-2280.
46. Kawanaka, N., Yamamura, M., Aita, T., Morita, Y., Okamoto, A., Kawashima, M., Iwahashi, M., Ueno, A., Ohmoto, Y. and Makino, H. 2002. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis and Rheumatism 46(10):2578-2586.
47. Khan, A., Farah, C.S., Savage, N.W., Walsh, L.J., Harbrow, D.J. and Sugerman, P.B. 2003. Th1 cytokines in oral lichen planus. Journal of Oral Pathology and Medicine 32(2): 77-83.
48. King, N.J.C. and Thomas, S.R. 2007. Molecules in focus: Indoleamine 2,3-dioxygenase. International Journal of Biochemistry and Cell Biology 39:2167-2172.
49. Koide, N., Nishio, A., Sato, T., Sugiyama, A. and Miyagawa, S. 2004. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the oesophagus. American Journal of Gastroenterology 99:1667-1674.
50. Kono, T., Tanii, T., Furukawa, M., Mizuno, N., Taniguchi, S., Ishii, M. and Hamada, T. 1990. Effects of human recombinant tumour necrosis factor-alpha (TNF-alpha) on the proliferative potential of human keratinocytes cultured in serum-free medium. Journal of Dermatology 17(7):409-413.
51. Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., Lackner, A., Alvarez, X., Ochoa, A., Chen, L. and Zou, W. 2006. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. Journal of Experimental Medicine 203:871-881.
52. Kuropkat, C, Dunne, A.A., Plehn, S., Ossendorf, M., Herz, U., Renz, H. and Werner, J.A. 2003. Macrophage colony stimulating factor as a tumour marker for squamous cell carcinoma of the head and neck. Tumour Biology 24:236-240.
53. Lalla, R.V., Boisoneau, D.S., Spiro, J.D. and Kreutzer, D.L. 2003. Expression of vascular endothelial growth factor receptors on tumour cells in head and neck squamous cell carcinoma. Archives in Otolaryngology Head and Neck Surgery 129:882-888.
54. Levings, M.K., Bacchetta, R., Schulz, U. and Roncarolo, M.G. 2002. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. International Archives of Allergy and Immunology 129:263-276.
55. Lewkowicz, N., Lewkowicz, P., Dzitko, K., Kur, B., Tarkoski, M., Kurnatowska, A. and Tchorzewski, H. 2007. Dysfunction of CD4+CD25+ high T regulatory cells in patients with recurrent aphthous stomatitis. Journal of Oral Pathology and Medicine 37:454-461.
56. Li, J., Ireland, G.W., Farthing, P.M. and Thornhill, M.H. 1996. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. Journal of Investigative Dermatology 106:661-666.
57. Li, J., Farthing, P.M. and Thornhill, M.H. 2000. Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-alpha and interferon-gamma. Journal of Oral Pathology and Medicine 29:438-444.
58. Li, C., Shintani, S., Terakado, N., Nakashiro, K. and Hamakawa, H. 2002. Infiltration of tumour-associated macrophages in human oral squamous cell carcinoma. Oncology Reports 9:1219-1223.
59. Liao, C.M., Zimmer, M.I., Shanmuganad, S., Yu, H.T., Cardell, S.L. and Wang, C.R. 2011. Dysregulation of CD1d-restricted type II natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology November 2. E-pub.
60. Lodes, M.J., Cong, Y., Elson, C.O., Mohamath, R., Landers, C.J., Targan, S.R., Fort, M. and Hershberg, R.M. 2004. Bacterial flagellin is a dominant antigen in Crohn's disease. Journal of Clinical Investigation 113(9): 1296-1306.
61. Mahanonda, R., Sa-Ard-Iam, N., Montreekachon, P., Pimkhaokham, A., Yongvanichit, K., Fukuda, M.M. and Pichyangkul, S. 2007. IL-8 and IDO expression by human gingival fibroblasts via TLRs. Journal of Immunology 178:1151-1157.
62. Mahida, Y.R. 2000. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflammatory Bowel Diseases 6(1):21-33.
63. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S. and Ruco, L. 1992. The origin and function of tumour-associated macrophages. Immunology Today 13:265-270.
64. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M. 2004. The chemokine system in diverse forms of macrophage activation and polarisation. Trends in Immunology 25(12):677-686.
65. Mantovani, A., Sica, A., Allavena, P., Garlanda, C. and Locati, M. 2009. Tumour-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Human Immunology 70:325-330.
66. Mantovani, A. and Sica, A. 2010. Macrophages, innate immunity and cancer: balance, tolerance and diversity. Current Opinion in Immunology 22: 231-237.
67. Marchini, L., Campos, M.S., Silva, A.M., Paulino, L.C. and Nobrega, F.G. 2007. Bacterial diversity in aphthous ulcers. Oral Microbiology and Immunology 22:225-231.
68. Martinez, F.O., Gordon, S., Locati, M. and Mantovani, A. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarisation: new molecules and patterns of gene expression. Journal of Immunology 177:7303-7311.
69. Martinez, F.O., Sica, A., Mantovani, A. and Locati, M. 2008. Macrophage activation and polarisation. Frontiers in Bioscience 13:453-461.
70. McGuirk, P., McCann, C. and Mills, K.H.G. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. Journal of Experimental Medicine 195(2):221-231.
71. Medina-Contreras, O., Geem, D., Laur, O., Williams, I.R., Lira, S.A., Nusrat, A., Parkos, C.A. and Denning, T.L. 2011. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation and colitogenic Th17 responses in mice. Journal of Clinical Investigation 121(12):4787-4795.
72. Mellor, A.L. and Munn, D.H. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Reviews in Immunology 4:762-774.
73. Mendes, D., Correia, M., Barbedo, M., Vaio, T., Mota, M., Goncalves, O. and Valente, J. 2009. Behcet's disease - a contemporary review. Journal of Autoimmunity 32:178-188.
74. Merry, R., Belfield, L., McArdle, P., McLennan, A., Crean, S-J. and Foey, A. 2012. Oral health and pathology: a macrophage account. British Journal of Oral and Maxillofacial Surgery 50:2-7.
75. Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J. and Hill, A.M. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. Journal of Immunology 164:6166-6173.
76. Mohammadi, M., Hayatbakhsh, M.M., Zahedi, M.J., Jalalpour, M.R. and Pakgohar, A. 2011. Serum interleukin-23 levels in patients with ulcerative colitis. Iran Journal of Immunology 8(3):183-188.
77. Montaner, L.J., da Silva, R.P., Sun, J., Sutterwala, S., Hollinshead, M., Vaux, D. and Gordon, S. 1999. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN or IL-10. Journal of Immunology 162: 4606-4613.
78. Mosser, D.M. and Edwards, J.P. 2008. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 8:958-969.
79. Murry, C.E., Giachelli, C.M., Schwartz, S.M. and Vracko, R. 1994. Macrophages express osteopontin during repair of myocardial necrosis. American Journal of Pathology 145:1450-1462.
80. Natah, S.S., Konttinen, Y.T., Enattah, N.S., Ashammakhi, N., Sharkey, K.A. and Hayrinen-Immonen, R. 2004. Recurrent aphthous ulcers today: a review of the growing knowledge. International Journal of Oral and Maxillofacial Surgery 33:221-234.
81. Neurath, M.F., Becker, C. and Barbulescu, K. 1998. Role of NF-kB in immune and inflammatory responses in the gut. Gut. 43:856-860.
82. Noel, W., Raes, G., Hassanzadeh-Ghassabeh, G., De Baetselier, P. and Beschin, A. 2004. Alternatively activated macrophages during parasite infections. Trends in Parasitology 20(3):126-133.
83. Novak, N., Haberstok, J., Bieber, T. and Allam, J-P. 2008. The immune privilege of the oral mucosa. Trends in Molecular Medicine 14(5):191-198.
84. Okada, Y., Tsuzuki, Y., Hokari, R., Komoto, S., Kurihara, C., Kawaguchi, A., Nagao, S. and Miura, S. 2009. Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I B and SOCS gene expression. International Journal of Experimental Pathology 90:131-140.
85. O'Neill, L.A.J. 2008. When signalling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29:12-20.
86. Parrello, T., Monteleone, G., Cucchiara, S., Monteleone, I., Sebkova, L., Doldo, P., Luzza, F. and Pallone, F. 2000. Up-regulation of the IL-12 receptor 2 chain in Crohn's disease. Journal of Immunology 165: 7234-7239.
87. Pesce, J., Kaviratne, M., Ramalingam, T.R., Thompson, R.W., Urban, J.F., Cheever, A.W., Young, D.A., Collins, M., Grusby, M.J. and Wynn, T.A. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. Journal of Clinical Investigation 116(7):2044-2055.
88. Platt, A.M. and Mowat, A.M. 2008. Mucosal macrophages and the regulation of immune responses in the intestine. Immunology Letters 119:22-31.
89. Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., Mantovani, A. and Sica, A. 2009a. Tolerance and M2 (alternative) macrophage polarisation are related processes orchestrated by p50 nuclear factor kappaB. Proceedings of the National Academy of Science USA 106:14978-14983.
90. Porta, C., Larghi, P., Rimoldi, M., Totaro, M.G., Allavena, P., Mantovani, A. and Sica, A. 2009b. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 214:761-777.
91. Rogler, G., Hausmann, M., Spottl, T., Vogl, D., Aschenbrenner, E., Andus, T., Falk, W., Scholmerich, J. and Gross, V. 1999. T cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa. European Journal of Gastroenterology and Hepatology 11(10):1105-1111.
92. Schenk, M., Bouchon, A., Birrer, S., Colonna, M. and Mueller, C. 2005. Macrophages expressing triggering receptor expressed on myeloid cells-1 are under-represented in the human intestine. Journal of Immunology 174:517-524.
93. Schenk, M. and Mueller, C. 2007. Adaptations of intestinal macrophages to an antigen-rich environment. Seminars in Immunology 19:84-93.
94. Schenk, M., Bouchon, A., Seibold, F. and Mueller, C. 2007. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel disease. Journal of Clinical Investigation 117(10):3097-3106.
95. Scully, C. and Porter, S. 2007. Oral mucosal disease: recurrent aphthous stomatitis. British Journal of Oral and Maxillofacial Surgery 46:198-206.
96. Sica, A., Schioppa, T., Mantovani, A. and Allavena, P. 2006. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. European Journal of Cancer 42(6):717-727.
97. Sica, A., Allavena, P. and Mantovani, A. 2008. Cancer related inflammation: the macrophage connection. Cancer Letters 264:204-215.
98. Simark-Mattsson, C., Bergenholtz, G., Jontell, M., Eklund, C., Seymour, G.J., Sugerman, P.B., Savage, N.W. and Dahlgren, U.I. 1999. Distribution of interleukin-2,-4,-10, tumour necrosis factor- and transforming growth factor- mRNAs in oral lichen planus. Archives of Oral Biology 44(6):499-507.
99. Sironi, M., Martinez, F.O., D'Ambrosio, D., Gattorno, M., Polentarutti, N., Locati, M., Gregorio, A., Lellem, A., Cassatella, M.A., Van Damme, J., Sozzani, S., Martini, A., Sinigaglia, F., Vecchi, A. and Mantovani, A. 2006. Differential regulation of chemokine production by Fc receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, type 2). Journal of Leukocyte Biology 80:342-249.
100. Smith, P.D., Smythies, L.E., Mosteller-Barnum, M., Sibley, D.A., Russell, M.W., Merger, M., Sellers, M.T., Orenstein, J.M., Shimada, T., Graham, M.F. and Kubagawa, H. 2001. Intestinal macrophages lack CD14 and CD89 and consequently down-regulated for LPSand IgA-mediated activities. Journal of Immunology 167(5):2651-2656.
101. Smith, P.D., Ochsenbauer-Jambor, C. and Smythies, L.E. 2005. Intestinal macrophages: unique effector cells of the innate immune system. Immunological Reviews 206:149-159.
102. Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G., Benjamin, W.H., Orenstein, J.M. and Smith, P.D. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. Journal of Clinical Investigation 115(1):66-75.
103. Solinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A. and Allavena, P. 2010. Tumourconditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarisation, influencing tumour cell motility. Journal of Immunology 185:642-652.
104. Song, E., Ouyang, N., Horbelt, M., Antus, B., Wang, M. and Exton, M.S. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cellular Immunology 204(1):19-28.
105. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. and Remaut, E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352-1355.
106. Strober, W., Fuss, I. and Blumberg, R. 2002. The immunology of mucosal models of inflammation. Annual Reviews in Immunology 20:495-549.
107. Sugerman, P.B., Savage, N.W., Seymour, G.J. and Walsh, L.J. 1996. Is there a role for tumour necrosis factor-alpha (TNF-alpha) in oral lichen planus? Journal of Oral Pathology and Medicine 25:219-224.
108. Sugerman, P.B., Savage, N.W., Walsh, L.J., Zhao, Z.Z., Zhou, X.J., Khan, A., Seymour, G.J. and Bigby, M. 2002. The pathogenesis of oral lichen planus. Critical Reviews in Oral Biology and Medicine 13:350-365.
109. Sugerman, P.B., Savage, N.W., Zhou, X.J., Walsh, L.J. and Bigby, M. 2000. Oral lichen planus. Clinical Dermatology 18:533-539.
110. Sutterwala, F.S., Noel, G.J., Salgame, P. and Mosser, D.M. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. Journal of Experimental Medicine 188(1):217-222.
111. Tabdir, A.A., Ashraf, M.J. and Sardari, Y. 2009. Prognostic significance of stromal eosinophilic infiltration in oral squamous cell carcinoma. Journal of Craniofacial Surgery 20:287-289.
112. Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10(1):39-49.
113. Thornhill, M.H. 2001. Immune mechanisms in oral lichen planus. Acta Odontology Scandinavia 59:174-177.
114. Verreck, F.A., de Boer, T., Langenberg, D.M., Hoeve, M.A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R. and Ottenhoff, T.H. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proceedings of the National Academy of Science USA 101(13):4560-4565.
115. Wang, F., Arun, P., Freidman, J., Chen, Z. and Van Waes, C. 2009. Current and potential inflammation targetted therapies in head and neck cancer. Current Opinion in Pharmacology 9:389-395.
116. Watanabe, H., Iwase, M., Ohashi, M. and Nagumo, M. 2002. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncology 38:670-679.
117. Weintraub, A., Zahringer, U., Wollenweber, H.W., Seydel, U., and Rietschel, E.T. 1989. Structural characterisation of the lipid A component of Bacteroides fragilis strain NCTC9343 lipopolysaccharide. European Journal of Biochemistry 183:425-431.
118. Wilson, H.M., Chettibi, S., Jobin, C., Walbaum, D., Rees, A.J. and Kluth, D.C. 2005. Inhibition of macrophage nuclear factor- B leads to a dominant anti-inflammatory phenotype that attenuates glomerular infiltration in vivo. American Journal of Pathology 167(1):27-37.
119. Xavier, R.J. and Podolsky, D.K. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434.
120. Yamamoto, T., Osaki, T., Yoneda, K. and Ueta, E. 1994. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. Journal of Oral Pathology and Medicine 23:309-315.
121. Young, M.R., Wright, M.A., Lozano, Y., Matthews, J.P., Benefield, J. and Prechel, M.M. 1996. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. International Journal of Cancer 67: 333-338.
122. Zhou, X.J., Sugerman, P.B., Savage, N.W. and Walsh, L.J. (2001). Matrix metalloproteinases and their inhibitors in oral lichen planus. Journal of Cutaneous Pathology 28:72-82.
123. + blood monocytes exhibits features of tissue macrophages. European Journal of Immunology 23(9): 2053-2058.
124. + subpopulation. Immunology Today 17(9):424-428.